Preface

This eBook entitled “Toward the Future: The New Challenges of the Cell Therapy and Potential of Regenerative Medicine” comprises chapters written by the leading experts in this field that provide state-of-the art information about the developments in important selected areas of Regenerative Medicine.

Regenerative Medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects.

This field holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable organs to heal themselves.

Regenerative Medicine also empowers scientists to grow tissues and organs in the laboratory and safely implant them when the body cannot heal itself.

Importantly, Regenerative Medicine has the potential to solve the problem of the shortage of organs available through donation compared to the number of patients that require life-saving organ transplantation.

Regenerative Medicine is also one of the fastest growing biomedical industries in the world because patients are being cured of diseases that were once incurable. Moreover, this field represents a new paradigm in human health because the vast majority of treatments for chronic and life-threatening disease focus on treating the symptoms, not curing the disease.

In fact, there are few therapies in use today capable of curing or significantly changing the course of a disease.

Stem cell therapy, when combined with immune and gene therapy, shows even greater potential to cure diseases. This new combination of regenerative cell therapies will open a new age of medicine, forever changing how it is practiced.

We would like to express our gratitude to all the Authors for their excellent contributions. We would also like to thank the entire team of Bentham Science Publishers, particularly Dr. Humaira Hashmi and Prof. Atta-ur-Rahman for their excellent efforts. We are confident that this Volume will receive wide appreciation from students and researchers.